Mesa Laboratories, Inc. (NASDAQ:MLAB) Plans $0.16 Quarterly Dividend

Mesa Laboratories, Inc. (NASDAQ:MLAB) declared a quarterly dividend on Wednesday, October 2nd,Zacks Dividends reports. Shareholders of record on Friday, November 29th will be paid a dividend of 0.16 per share by the medical instruments supplier on Monday, December 16th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.54%. The ex-dividend date of this dividend is Friday, November 29th.

Mesa Laboratories has a dividend payout ratio of 6.5% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Mesa Laboratories to earn $8.29 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 7.7%.

Mesa Laboratories Price Performance

Shares of Mesa Laboratories stock opened at $118.35 on Thursday. The business has a 50 day simple moving average of $120.99 and a two-hundred day simple moving average of $114.50. Mesa Laboratories has a 12 month low of $83.68 and a 12 month high of $141.17. The stock has a market capitalization of $642.64 million, a P/E ratio of -2.56 and a beta of 0.87. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.70 and a quick ratio of 0.51.

Wall Street Analyst Weigh In

A number of brokerages have commented on MLAB. Wells Fargo & Company began coverage on Mesa Laboratories in a report on Tuesday, August 27th. They set an “underweight” rating and a $120.00 target price for the company. StockNews.com cut Mesa Laboratories from a “buy” rating to a “hold” rating in a report on Wednesday, November 13th. Finally, Evercore ISI increased their target price on Mesa Laboratories from $120.00 to $160.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st.

Insider Activity at Mesa Laboratories

In related news, SVP Brian David Archbold sold 1,499 shares of the stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $125.00, for a total value of $187,375.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Gary M. Owens sold 2,518 shares of the stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $113.62, for a total value of $286,095.16. Following the completion of the transaction, the chief executive officer now owns 45,888 shares of the company’s stock, valued at $5,213,794.56. The trade was a 5.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 4.40% of the company’s stock.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.